Ruty Ben Shlomi
CIK: 0002154341
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLGN
CollPlant Biotechnologies Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Shlomi Ruty Ben
Shlomi Ruty Ben (SEC CIK 0002154341) files insider reports with the SEC as Director of CollPlant Biotechnologies Ltd (CLGN).
Signal8 holds 1 ownership filing by Shlomi Ruty Ben, a Form 3, filed on Oct 19, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Shlomi Ruty Ben's filings is in REHOVOT.
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Rotem Eran, Deputy CEO and CFO
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Tal Yehiel, Chief Executive Officer
- Lask Alisa, Director
- Penn Elan, Director